Back to News
Market Impact: 0.2
Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock?
Source: zacks.com
Analyst EstimatesMarket Technicals & FlowsHealthcare & Biotech
Surgery Partners shares surged in the latest session on above-average trading volume. The article indicates that favorable earnings-estimate revision momentum could support further near-term upside, though it provides no specific revision, price, or volume figures.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
SGRY0.55
More News
- OpenAI’s agent hacked Australia’s Medicare website—the latest rogue AI incident that the company didn’t know about for months
- Australia says OpenAI agent hacked Medicare portal
- Bond yields spike and stocks drop — plus, why Boeing is bucking the trend
- US aviation sanctions disrupt Iran flights, push travellers overland
- Nasdaq Sells Off From Record Highs As Treasury Yields Surge; These Stocks Hit Buy Points
- Meta Debuts $349 Camera-Free Ray-Bans and Brings Muse to Glasses
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Stop Treating AI Like a Chatbot: What Are Agents, SubAgents, MCP, and Skills, and How Do They Actually Work?
- Earnings-Triggered Research Automations: A Control Guide